SCHEMBL25858346

SCHEMBL25858346

CCn1nc(C2CCC(=O)NC2=O)c2ccccc21

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 20/20 0.72
DDB1 Q16531 19/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20805565 0.87 DDB1 (0.70) CRBNDDB1
SCHEMBL24669902 0.86 DDB1 (0.65) CRBNDDB1
SCHEMBL24670641 0.84 DDB1 (0.66) CRBNDDB1
SCHEMBL30273604 0.84 DDB1 (1.00) CRBNDDB1
SCHEMBL20805180 0.84 DDB1 (1.00) CRBNDDB1
SCHEMBL19586142 0.84 DDB1 (1.00) CRBNDDB1
SCHEMBL20805181 0.84 DDB1 (1.00) CRBNDDB1
SCHEMBL25857088 0.82 CRBN (0.59) CRBNDDB1
SCHEMBL23553084 0.81 DDB1 (0.73) CRBNDDB1
SCHEMBL31202341 0.81 DDB1 (0.59) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed